- Home
- TRML vs QCRH Comparison
TRML vs QCRH Comparison
Compare TRML & QCRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRML
- QCRH
- Stock Information
- Founded
- TRML 2021
- QCRH 1993
- Country
- TRML United States
- QCRH United States
- Employees
- TRML N/A
- QCRH N/A
- Industry
- TRML Biotechnology: Pharmaceutical Preparations
- QCRH Major Banks
- Sector
- TRML Health Care
- QCRH Finance
- Exchange
- TRML Nasdaq
- QCRH Nasdaq
- Market Cap
- TRML 1.2B
- QCRH 1.1B
- IPO Year
- TRML N/A
- QCRH 1993
- Fundamental
- Price
- TRML $47.97
- QCRH $73.66
- Analyst Decision
- TRML Hold
- QCRH Buy
- Analyst Count
- TRML 12
- QCRH 4
- Target Price
- TRML $47.04
- QCRH $87.38
- AVG Volume (30 Days)
- TRML 657.3K
- QCRH 105.3K
- Earning Date
- TRML 11-13-2025
- QCRH 10-22-2025
- Dividend Yield
- TRML N/A
- QCRH 0.33%
- EPS Growth
- TRML N/A
- QCRH 3.93
- EPS
- TRML N/A
- QCRH 7.15
- Revenue
- TRML N/A
- QCRH $336,623,000.00
- Revenue This Year
- TRML N/A
- QCRH N/A
- Revenue Next Year
- TRML N/A
- QCRH $14.20
- P/E Ratio
- TRML N/A
- QCRH $10.32
- Revenue Growth
- TRML N/A
- QCRH N/A
- 52 Week Low
- TRML $11.56
- QCRH $60.83
- 52 Week High
- TRML $48.27
- QCRH $96.08
- Technical
- Relative Strength Index (RSI)
- TRML 90.29
- QCRH 52.46
- Support Level
- TRML $47.88
- QCRH $66.71
- Resistance Level
- TRML $48.00
- QCRH $73.18
- Average True Range (ATR)
- TRML 0.05
- QCRH 2.45
- MACD
- TRML -0.84
- QCRH 0.09
- Stochastic Oscillator
- TRML 83.78
- QCRH 66.61
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
About QCRH QCR Holdings Inc.
QCR Holdings Inc is a multi-bank holding company. The bank operates through segments namely Commercial Banking, Wealth Management, and all other segments. The commercial bank segment is geographically divided by markets namely Quad City Bank & Trust (QCBT), Cedar Rapids Bank & Trust (CRBT), Community State Bank (CSB) and Guaranty Bank (GB). It generates revenue in the form of interest.